Are Topical Corticoids Efficacious in Acute Irritant Dermatitis: The Evidence.
Administration, Cutaneous
Betamethasone Valerate
/ therapeutic use
Clobetasol
/ therapeutic use
Dermatitis, Irritant
/ drug therapy
Glucocorticoids
/ administration & dosage
Humans
Hydrocortisone
/ therapeutic use
Ointments
Triamcinolone Acetonide
/ therapeutic use
Water Loss, Insensible
/ drug effects
Journal
Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335
Informations de publication
Date de publication:
Historique:
entrez:
16
7
2020
pubmed:
16
7
2020
medline:
6
5
2021
Statut:
ppublish
Résumé
Topical corticosteroid therapies are widely utilized, despite the controversial results of corticoid therapy in irritant contact dermatitis as a local inflammatory reaction after repeated or single skin exposure to a chemical substance. Although corticoids may reduce the inflammatory response to the irritant, their antiproliferative effects may reduce skin barrier recovery while allowing further penetration of irritants if exposure continues. This overview reexamines the efficacy of corticosteroids in irritant contact dermatitis therapy, and with the minimal controlled experimental data currently available, notes the need for same-in this common clinical entity.
Identifiants
pubmed: 32665512
doi: 10.1097/DER.0000000000000574
pii: 01206501-202007000-00004
doi:
Substances chimiques
Glucocorticoids
0
Ointments
0
Betamethasone Valerate
9IFA5XM7R2
Clobetasol
ADN79D536H
Triamcinolone Acetonide
F446C597KA
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM